Bizarre Patents
Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7960336 | Composition for long-acting peptide analogs The invention describes compositions of peptide analogs exemplified by peptides derived from vasopressin, terlipressin, and GLP1 and others that are active in blood or cleavable in blood to release an active peptide. The peptide analogs have a general formula: A-(Cm... | 06/14/2011 |
| 7439225 | Substances K01-B0171 and process for producing the same The present invention is comprised of culturing a microorganism having ability to produce K01-B0171-B substance and/or K01-B0171-C substance in a medium, accumulating K01-B0171-B substance and/or K01-B0171-C substance in a culture fluid and isolating K01-B0171-B sub... | 10/21/2008 |
| 7326700 | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists The present invention provides tricyclic carboxamide compounds and methods and pharmaceutical compositions for their use in treatment, prevention, or suppression of disorders which may be remedied or alleviated by oxytocin antagonist activity, including prevention a... | 02/05/2008 |
| 7276251 | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles... | 10/02/2007 |
| 7265200 | 1-desamino-8-D-arginyl vasopressin analogs Analogs of 1-desamino-8-D-arginyl vasopressin having the formula: wherein, X and Y are amino acids as defined herein, useful as an anti-diuretic or as an inhibitor of metastasis and cancer cell migration. ... | 09/04/2007 |
| 7202239 | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists The present invention provides novel tricyclic benzodiazepine carboxamides compounds and methods and pharmaceutical compositions utilizing them for the treatment and/or prevention and/or suppression of disorders which may be remedied or alleviated by oxytocin antago... | 04/10/2007 |
| 7160853 | Protocol for paracentesis The present invention relates to an improved method for the treatment of hypovolaemia or hypotension associated with therapeutic paracentesis, which method is characterised by the use of a peptide according to general formulae (I) or a salt thereof, wherin Asn, Cys,... | 01/09/2007 |
| 7109193 | Tricyclic diazepines tocolytic oxytocin receptor antagonists This invention provides novel tricyclic diazepine compounds as well as methods and pharmaceutical compositions utilizing these compounds for the treatment and/or prevention and/or suppression of disorders which may be remedied or alleviated by oxytocin antagonist ac... | 09/19/2006 |
| 7064120 | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists This invention provides novel substituted tricyclic pyridyl carboxamides which act as oxytocin receptor competitive antagonists, as well as methods of their manufacture, pharmaceutical compositions and methods of their use in treatment, inhibition, suppression or pr... | 06/20/2006 |
| 7045497 | Use of peptide The present invention relates to use of peptide to which G-protein coupled receptor protein recognizes as a ligand. Since the ligand polypeptide of the present invention has a stimulating action on oxytocin secretion, it is useful as a drug for ameliorating, preserv... | 05/16/2006 |
| 7022699 | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators The present invention provides novel tricyclic diazepine compounds and methods and pharmaceutical compositions utilizing them for the treating or preventing disorders including diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, bleeding and coag... | 04/04/2006 |
| 6995236 | Sphingomyelin detecting probe An object of the present invention is to provide a protein useful as a sphingomyelin detecting probe, which specifically recognizes sphingomyelin and has low cytotoxicity. The present invention provides a protein which has an amino acid sequence having, as the amino... | 02/07/2006 |
| 6858210 | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same The present invention provides domain 1 β2GPI polypeptides, polynucleotides encoding these polypeptides, mimetics of these polypeptides, and methods using domain 1 β2GPI polypeptides and mimetics. Domain 1 of β2GPI has been shown ... | 02/22/2005 |
| 6673769 | Lanthionine bridged peptides Disclosed are lanthionine bridged peptides having the structure ##STR1## methods of their preparation and their use as pharmacologically active agents.... | 01/06/2004 |
| 6380155 | Use of vasopressin receptor antagonist for regulation of ACTH release A method for normalising abnormally elevated ACTH release in mammals, such as humans, which method comprises the administration of an effective, non-toxic amount of a compound which regulates the biological activity of the arginine vasopressin V1b recepto... | 04/30/2002 |
| 6268339 | Lanthionine bridged peptides Disclosed are lanthionine bridged peptides having the structure ##STR1## methods of their preparation and their use as pharmacologically active agents.... | 07/31/2001 |
| 6262021 | Use of substances having oxytocin activity for preparation of medicaments for wound healing Substances having oxytocin activity can be used for the preparation of a pharmaceutical composition for the curative or prophylactic treatment of wounds, such as chronic wounds. The wound healing effect can be strengthened or prolonged by combining oxytoc... | 07/17/2001 |
| 6228836 | Permucous preparation A composition for permucosal administration characterized by containing Antago-3 or a physiologically acceptable salt thereof, and a sucrose fatty acid ester. With the composition for permucosal administration of the invention there is provided a long-ter... | 05/08/2001 |
| 6143722 | Heptapeptide oxytocin analogues Heptapeptide analogues or pharmaceutically acceptable salts thereof consist of a hexapeptide moiety S and a C-terminal ଲ-aminoalcohol residue Z bound to the moiety S by an amide bond, wherein the ଲ-aminoalcohol Z is --NR--CH(Q)--CH2... | 11/07/2000 |
| 6093692 | Method and compositions for lipidization of hydrophilic molecules Fatty acid derivatives of disulfide-containing compounds (for example, disulfide-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage are employed for delivery of the compounds to mammalian cells. This modifi... | 07/25/2000 |
| 6028168 | Lanthionine bridged peptides Disclosed are lanthionine peptides having the structure ##STR1## methods of their preparation and use as pharmacologically active agents.... | 02/22/2000 |
| 5990273 | Synthesis of cyclic peptides A process for preparing and purifying cyclic peptides having disulfide moieties in a two step processing operation including reverse phase chromatography which simplifies synthesis and reduces production costs, yet produces high, quality yield. The improv... | 11/23/1999 |
| 5939381 | Compounds and compositions for delivering active agents Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.... | 08/17/1999 |
| 5922680 | Stabilized composition for oral administration of peptides A solid pharmaceutical composition for oral administration of small and medium size peptides, particularly vasopressin, oxytocin, and their analogues, comprises said peptide, an enteric coat and a pharmaceutically acceptable carrier containing a buffering... | 07/13/1999 |
| 5849261 | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy This invention relates to radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic and radiotherapeutic agents. Specifically, the invention relates to VIP receptor binding peptides, d... | 12/15/1998 |
| 5843903 | Targeted cytotoxic anthracycline analogs This invention is in the field of the chemistry of targeting anticancer anthracycline derivatives. More particularly, it concerns doxorubicin (DOX) or its daunosamine modified derivatives (DM-DOX) linked covalently to analogs of peptide hormones such as L... | 12/01/1998 |
| 5827893 | Mechanical and pharmacological therapies to treat cardiac arrest A pharmaceutical composition is provided which comprises vasopressin and an adrenergic agent in combination with a pharmaceutically acceptable carrier. The pharmaceutical composition is effective to increase arterial blood pressure so as to enhance arteri... | 10/27/1998 |
| 5763405 | Stabilized composition for oral administration of peptides A solid pharmaceutical composition for oral administration of small and medium size peptides, particularly vasopressin, oxytocin, and their analogues, comprises said peptide, an enteric coat and a pharmaceutically acceptable carrier containing a buffering... | 06/09/1998 |
| 5756344 | DNA coding for a human vasoconstrictive peptide and use thereof Disclosed are (1) a DNA containing a cDNA segment coding for human endothelin-2 (SEQ ID NO:1), (2) a precursor of human endothelin-2 (SEQ ID NO:2), (3) a transformant carrying a DNA containing a cDNA segment coding for human endothelin-2, and (4) a method... | 05/26/1998 |
| 5726287 | Synthesis of cyclic peptides A process for preparing and purifying cyclic peptides having disulfide moieties in a single processing operation which simplifies synthesis and reduces production costs, yet produces high, quality yield. Higher yields are obtained by isolating the desired... | 03/10/1998 |
| 5698516 | Biologically active vasopressin analogues Vasopressin analogues of formula (I) ##STR1## wherein X is (S)-2-amino-2-methyl-butanoic acid (CaMeAbu) or Valine (Val), Y is Thienylalanine (Thi) or Methionine (Met), Z is D-Phenylalanine (D-Phe) or D-Thienylalanine (Thi) or D-Tyrosine (D-Tyr), are ... | 12/16/1997 |
| 5627268 | Hemoglobin comprising globin fusion proteins The present invention relates to a novel method for making a predetermined, desired peptide in transgenic animals and can be advantageously used for the production of large quantities of the desired peptide. More particularly, the invention concerns the e... | 05/06/1997 |
| 5618791 | Memory enhancing peptides The invention is a class of memory enhancing peptides having the general formula: R1 --Asn--X1 --X2 --X3 --R2 where R1 =pyroglutamyl, acetyl, H, peptidyl X1 =Ala, Ile, Leu, Tyr, Phe, Val, ... | 04/08/1997 |
| 5596078 | Synthesis of cyclic peptides A process for preparing and purifying cyclic peptides having disulfide moieties in a single processing operation which simplifies synthesis and reduces production costs, yet produces high, quality yield. Higher yields are obtained by isolating the desired... | 01/21/1997 |
| 5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin A process for the manufacture of 1-deamino-8-D-arginine vasopressin (DDAVP) comprising, condensing a preparation of Mpa(R1)-Tyr-Phe-Gln-Asn-Cys(R2)-Pro-OH (SEQ ID NO: 1), where R1 and R2 are sulfhydryl-protectin... | 03/19/1996 |
| 5486596 | Analogues of 8-D-homoarginine vasopressin Analogues of 8-D-homoarginine vasopressin were prepared with the general formula ##STR1## where X is L-O-methyltyrosine, L-p-ethylphenylalanine, D-p-ethylphenylalanine, L-p-methylphenylalanine or D-methylphenylalanine and R is cysteine or ³... | 01/23/1996 |
| 5482931 | Stabilized pharmaceutical peptide compositions Disclosed is a stabilized aqueous composition for administration to a patient comprising a biologically active peptide, a buffer, a quaternary amine-type preservative or disinfectant, and an osmotic pressure-controlling agent, which composition can be sto... | 01/09/1996 |
| 5470948 | Vasopressin and vasotocin derivatives This invention relates to new vasopressin and vasotocin derivatives of general formula I ##STR1## in which A stands for the radical Mca (=3-mercapto-3,3-cyclpentamethylenepropionyl radical) or for the radical Mpa (=3-mercaptopropionyl radical), ... | 11/28/1995 |
| 5459236 | Vasoactive vasotocin derivatives The present invention relates to new vasotocin derivatives with prolonged activity compared to previous vasotocin derivatives. In particular, the vasotocin derivatives of the present invention are of the formula (I) ##STR1## wherein Hmp is a 2-hydrox... | 10/17/1995 |
| 5459077 | Methods for modelling tertiary structures of biologically active ligands and for modelling agonists and antagonists thereto Disclosed are methods for modelling the three-dimensional structure (tertiary structure) of a ligand having one or more active sites employing a charge-transfer interaction. Also disclosed is a model for Angiotensin II derived from such method.... | 10/17/1995 |
